Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
about
Emollients and moisturisers for eczemaMolecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic DermatitisAdvances in understanding and managing atopic dermatitisRole of Dendritic Cells in the Induction of Lymphocyte ToleranceImmune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsChange of paradigm: CD8+ T cells as important helper for CD4+ T cells during asthma and autoimmune encephalomyelitisDeciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesNew era of biologic therapeutics in atopic dermatitisThe ABC's of managing patients with severe atopic dermatitisThe Pathogenetic Effect of Natural and Bacterial Toxins on Atopic DermatitisRole of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in HumansMultiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and PathwaysDendritic Core-Multishell Nanocarriers in Murine Models of Healthy and Atopic SkinInteractive effect of STAT6 and IL13 gene polymorphisms on eczema status: results from a longitudinal and a cross-sectional study.TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis.The biodiversity hypothesis and allergic disease: world allergy organization position statement.Risk factors for eosinophilic esophagitis.Multifactorial Modulation of Food-Induced AnaphylaxisLow prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis.Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapyAtopic dermatitis phenotypes in childhoodExperimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.An important role of α-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureusTh2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age.Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionEffects of in utero exposure of C57BL/6J mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin on epidermal permeability barrier development and functionCoal tar induces AHR-dependent skin barrier repair in atopic dermatitisGene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinaeStaphylococcal and streptococcal superantigen exotoxinsThe genetics of human skin disease.Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammationAtopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Harmful Effects of Synthetic Surface-Active Detergents against Atopic Dermatitis.Critical role for mast cell Stat5 activity in skin inflammation
P2860
Q24186075-FA4158CA-2A0B-4A67-A786-E7A5888111CEQ26739986-804C0BA9-4025-47F9-A0CE-DA7D903D6B87Q26766224-58D70876-6944-4CC4-A439-AEF800A48613Q26779405-4E3B6FB7-F3D1-4C3C-ADD8-261A66E2FE9CQ26799532-BEB080BA-9C00-420F-BD81-4992CE42C2A4Q26824572-B0D12021-54CD-49E9-A730-A58143766872Q26852335-2B6AB72B-E323-40D5-BA4F-1B5A164F2FE5Q27001941-73651077-038D-416E-AD9C-7E44EFEAF351Q27022610-415E1C00-9408-4263-824E-97DF28274278Q28068840-B9D30B66-1CCA-4914-9C80-CF43C4E683A3Q28080555-BCA221E2-4890-4A48-B55E-1D8A2AA1F903Q28397937-F865BC74-7FF0-4AB7-8D4E-6CA4FB099D30Q29249083-FF9AB8E4-F7A1-45EF-A7C5-297396F2DF8BQ30541150-9CA5D7CC-012C-4EDC-BC86-AEB0A9B0EB5BQ30587902-68B71A27-608E-41AF-9FB9-0A22EDD2BCA6Q30624202-B8FCBFCD-94A5-4FAF-B519-2BDF68C1265CQ31170219-8D852AFE-4D15-41B3-8C6E-9F073A629456Q33690086-419590D3-817B-4F9C-A49E-C70FF1571A84Q33712334-A07CD64B-CA5B-4289-82C4-1F1F51FE0A3AQ33713754-5E335627-E51A-4C70-B554-05A137EF4E58Q33776717-58232390-37C0-4BC3-B408-0981A5646D5EQ33815955-D8685B3D-E0CD-4EF9-A784-3A8708990634Q33854831-F5276672-C085-433E-A6EC-A0A3CF9C4E19Q33916807-FF6C081C-D32D-4619-98E3-7DD91AA1B8A8Q34006054-44662217-5688-477D-B4FF-575BA5B151D0Q34081764-BED9D7C3-8D90-4E28-9BCD-32B67001DC3BQ34109984-A9141E91-60C0-4F02-923F-6A4238298EDFQ34165569-A6D7CC22-39B7-416B-B33D-45770185003BQ34189662-C970BAF6-1750-4012-A886-4353BC67112AQ34266725-DD773785-0A09-4834-8E9D-45765BD298C9Q34275373-A5541E78-350C-40FB-88B3-B7913C4C45A7Q34324282-16D78006-FAA5-4ED9-97E4-E1F78AA9C5CAQ34351982-B4EAE162-4B45-416C-9686-97EE0D0AFD97Q34355243-200FE485-74F6-4BFF-A6DD-DA1B6BCFBF6DQ34355367-61E0D56A-B648-435E-BE0A-65414994E49BQ34531749-F1B4DBCF-308A-41D1-BB3F-CD924A015407Q34734569-98E7F60A-C24F-44D0-BC9F-EAB02B9C3410Q34797596-CE602C20-A641-4E8A-9A37-65F693405D19Q35026030-76F208E6-BF06-4471-9E54-8E7ADFDE5DD7Q35087816-789519B3-DDDE-440D-9487-5BB507FFEDAA
P2860
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@ast
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@en
type
label
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@ast
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@en
prefLabel
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@ast
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@en
P2860
P1476
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.
@en
P2093
Donald Y M Leung
Mark Boguniewicz
P2860
P304
P356
10.1111/J.1600-065X.2011.01027.X
P577
2011-07-01T00:00:00Z